Perioperative mortality in Colombia: Perspectives of the fourth indicator in The Lancet Commission on Global Surgery – Colombian Surgical Outcomes Study (ColSOS) – a protocol for a multicentre prospective cohort study

Carlos J. Pérez-Rivera, Nicolás Lozano-Suárez, Alejandro Velandia-Sánchez, Camilo A. Polanía-Sandoval, Juan P. García-Méndez, Sharon V. Idarraga-Ayala, Julián M. Corso-Ramírez, Danny Conde-Monroy, Danna L. Cruz-Reyes, Carlos F. Durán-Torres, Juan G. Barrera-Carvajal, Luisa Fernanda Rojas-Serrano, Laura Alejandra Garcia-Zambrano, Silvia Valentina Agudelo-Mendoza, Leonardo Briceno-Ayala, Paulo A. Cabrera-Rivera

Research output: Contribution to journalResearch Articlepeer-review

2 Scopus citations

Abstract

Introduction: Death following surgical procedures is a global health problem, accounting for 4.2 million deaths annually within the first 30 postoperative days. The fourth indicator of The Lancet Commission on Global Surgery is essential as it seeks to standardise postoperative mortality. Consequently, it helps identify the strengths and weaknesses of each country's healthcare system. Accurate information on this indicator is not available in Colombia, limiting the possibility of interventions applied to our population. We aim to describe the in-hospital perioperative mortality of the surgical procedures performed in Colombia. The data obtained will help formulate public policies, improving the quality of the surgical departments. Methods and analysis An observational, analytical, multicentre prospective cohort study will be conducted throughout Colombia. Patients over 18 years of age who have undergone a surgical procedure, excluding radiological/endoscopic procedures, will be included. A sample size of 1353 patients has been projected to achieve significance in our primary objective; however, convenience sampling will be used, as we aim to include all possible patients. Data collection will be carried out prospectively for 1 week. Follow-up will continue until hospital discharge, death or a maximum of 30 inpatient days. The primary outcome is perioperative mortality. A descriptive analysis of the data will be performed, along with a case mix analysis of mortality by procedure-related, patient-related and hospital-related conditions Ethics and dissemination The Fundación Cardioinfantil-Instituto de Cardiología Ethics Committee approved this study (No. 41-2021). The results are planned to be disseminated in three scenarios: the submission of an article for publication in a high-impact scientific journal and presentations at the Colombian Surgical Forum and the Congress of the American College of Surgeons. Trial registration number NCT05147623.

Translated title of the contributionMortalidad perioperatoria en Colombia: perspectivas del cuarto indicador en The Lancet Commission on Global Surgery – Colombian Surgical Outcomes Study (ColSOS) – un protocolo para un estudio de cohorte prospectivo multicéntrico
Original languageEnglish (US)
Article numbere063182
Pages (from-to)1-10
Number of pages10
JournalBMJ Open
Volume12
Issue number11
DOIs
StatePublished - Nov 30 2022

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'Perioperative mortality in Colombia: Perspectives of the fourth indicator in The Lancet Commission on Global Surgery – Colombian Surgical Outcomes Study (ColSOS) – a protocol for a multicentre prospective cohort study'. Together they form a unique fingerprint.

Cite this